Gabelli & Co Investment Advisers’s Alimera Sciences ALIM Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60,650	Closed	-$337K	–	268
2024 Q2	$337K	Buy	+60,650	New	+$215K	0.06%	153

Gabelli & Co Investment Advisers's ALIM Position: Q3 2024 in Review

Gabelli & Co Investment Advisers sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 60,650 shares — an estimated $337K sold.

Gabelli & Co Investment Advisers first reported a position in ALIM in Q2 2024 and held it in 1 quarter. The position peaked at $337K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Gabelli & Co Investment Advisers reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 60,650 Alimera Sciences shares in Q3 2024, an estimated $337K.
Gabelli & Co Investment Advisers first reported a position in Alimera Sciences in Q2 2024 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Alimera Sciences position peaked at $337K in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.